CASI Pharmaceuticals, Inc. Ordinary Shares (CASI) Stock Price

CASIStock
$0.0027.08%52W
Market Cap
P/E
PEG Ratio
Div yield
Beta0.27

CASI Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-95.90%
Price vs S&P 500 (4W)-80.09%
VGM Score53.98

CASI Analyst Recommendations

Mar 2023
Apr 2023
May 2023
Jun 2023
4.25
4.25
4.25
4.14

About CASI Pharmaceuticals, Inc. Ordinary Shares

CASI Pharmaceuticals is a specialized biopharmaceutical company focused on oncology therapies for hematologic malignancies including leukemia, lymphoma, and multiple myeloma. The company's marketed products include EVOMELA, a conditioning agent for autologous stem cell transplant in multiple myeloma patients, along with MARQIBO and ZEVALIN. EVOMELA is the primary revenue driver.